Sunday 18 October 2026 Export GALT’s income statement to Excel — free account

Galectin Therapeutics Inc.

In the quarter to June 2026, EPS fell 16.7%, free cash flow grew 63.1% and total debt fell 13.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

3.62 0.09 −2.43%

Follow GALT

Alert me

Market cap: $374.2M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	21.69%	21.41%	26.51%	33.96%	+8 more TTM periods Free account
ROA Full definition →	(184.22%)	(209.09%)	(167.30%)	(178.99%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	20.46%	(315.31%)	(271.56%)	30.26%
Free Cash Flow per Share Full definition →	(0.24)	(0.30)	(0.37)	(0.48)
Free Cash Flow Full definition →	(15.89)	(20.05)	(23.87)	(30.62)
Other line items
Cash ROIC Full definition →	83.96%	(102.39%)	(94.52%)	137.32%
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	(2.02)	(2.15)	(2.74)	(4.10)
Operating CF/Net income Full definition →	0.57	0.76	0.77	0.82
Depreciation/Fixed assets Full definition →	0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.24)	(0.30)	(0.37)	(0.48)
Capex per Share Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly